Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands | Total | Common Stock | Paid-in Capital | Retained Earnings |
Beginning balance (in shares) at Sep. 30, 2020 | | 11,822,009 | | |
Beginning balance at Sep. 30, 2020 | $ 14,933 | $ 118 | $ (2,567) | $ 17,382 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net loss | (1,953) | | | (1,953) |
Common stock issuance (in shares) | | 238,194 | | |
Common stock issuance | 879 | $ 3 | 876 | |
Restricted stock issuance (in shares) | | 306,390 | | |
Restricted stock issuance | 0 | $ 3 | (3) | |
Amortization of stock-based compensation | 315 | | 315 | |
Ending balance (in shares) at Dec. 31, 2020 | | 12,366,593 | | |
Ending balance at Dec. 31, 2020 | 14,174 | $ 124 | (1,379) | 15,429 |
Beginning balance (in shares) at Sep. 30, 2020 | | 11,822,009 | | |
Beginning balance at Sep. 30, 2020 | 14,933 | $ 118 | (2,567) | 17,382 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net loss | (5,017) | | | |
Ending balance (in shares) at Mar. 31, 2021 | | 12,413,372 | | |
Ending balance at Mar. 31, 2021 | 11,465 | $ 124 | (1,023) | 12,364 |
Beginning balance (in shares) at Dec. 31, 2020 | | 12,366,593 | | |
Beginning balance at Dec. 31, 2020 | 14,174 | $ 124 | (1,379) | 15,429 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net loss | (3,064) | | | (3,064) |
Common stock issuance (in shares) | | 7,779 | | |
Common stock issuance | 21 | | 21 | |
Restricted stock issuance (in shares) | | (10,000) | | |
Restricted stock issuance | (1) | $ (1) | | |
Stock option exercise (in shares) | | 49,000 | | |
Stock option exercise | 89 | | 89 | |
Amortization of stock-based compensation | 246 | | 246 | |
Ending balance (in shares) at Mar. 31, 2021 | | 12,413,372 | | |
Ending balance at Mar. 31, 2021 | 11,465 | $ 124 | (1,023) | 12,364 |
Beginning balance (in shares) at Sep. 30, 2021 | | 12,610,229 | | |
Beginning balance at Sep. 30, 2021 | 10,427 | $ 126 | (578) | 10,879 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net loss | (2,029) | | | (2,029) |
Common stock issuance (in shares) | | 320,787 | | |
Common stock issuance | 636 | $ 3 | 633 | |
Restricted stock issuance (in shares) | | 110,111 | | |
Restricted stock issuance | 0 | $ 1 | (1) | |
Amortization of stock-based compensation | 281 | | 281 | |
Ending balance (in shares) at Dec. 31, 2021 | | 13,041,127 | | |
Ending balance at Dec. 31, 2021 | 9,315 | $ 130 | 335 | 8,850 |
Beginning balance (in shares) at Sep. 30, 2021 | | 12,610,229 | | |
Beginning balance at Sep. 30, 2021 | 10,427 | $ 126 | (578) | 10,879 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net loss | (3,422) | | | |
Ending balance (in shares) at Mar. 31, 2022 | | 13,189,112 | | |
Ending balance at Mar. 31, 2022 | 8,336 | $ 132 | 748 | 7,456 |
Beginning balance (in shares) at Dec. 31, 2021 | | 13,041,127 | | |
Beginning balance at Dec. 31, 2021 | 9,315 | $ 130 | 335 | 8,850 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net loss | (1,394) | | | (1,394) |
Common stock issuance (in shares) | | 143,985 | | |
Common stock issuance | 168 | $ 2 | 166 | |
Restricted stock issuance (in shares) | | 4,000 | | |
Amortization of stock-based compensation | 247 | | 247 | |
Ending balance (in shares) at Mar. 31, 2022 | | 13,189,112 | | |
Ending balance at Mar. 31, 2022 | $ 8,336 | $ 132 | $ 748 | $ 7,456 |